-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Integrated Biopharma Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2011 to 2024.
- Integrated Biopharma Inc Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $245K, a 1785% increase year-over-year.
- Integrated Biopharma Inc Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $388K, a 304% increase year-over-year.
- Integrated Biopharma Inc annual Income Tax Expense (Benefit) for 2024 was $156K, a 16.4% increase from 2023.
- Integrated Biopharma Inc annual Income Tax Expense (Benefit) for 2023 was $134K.
- Integrated Biopharma Inc annual Income Tax Expense (Benefit) for 2022 was -$1.24M, a 62% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)